The Role of Protein Kinase A Regulation of the E6 PDZ-Binding Domain during the Differentiation-Dependent Life Cycle of Human Papillomavirus Type 18 by Delury, C. P. et al.
The Role of Protein Kinase A Regulation of the E6 PDZ-Binding
Domain during the Differentiation-Dependent Life Cycle of Human
Papillomavirus Type 18
Craig P. Delury,a* Elizabeth K. Marsh,a Claire D. James,a Siaw Shi Boon,b Lawrence Banks,b Gillian L. Knight,a* Sally Robertsa
School of Cancer Sciences, Cancer Research UK Cancer Centre, University of Birmingham, Birmingham, United Kingdoma; International Centre for Genetic Engineering
and Biotechnology, Padriciano, Trieste, Italyb
Human papillomavirus (HPV) E6 proteins of high-risk alpha types target a select group of PSD95/DLG1/ZO1 (PDZ) domain-
containing proteins by using a C-terminal PDZ-binding motif (PBM), an interaction that can be negatively regulated by phos-
phorylation of the E6 PBM by protein kinase A (PKA). Here, we have mutated the canonical PKA recognition motif that partially
overlaps with the E6 PBM in the HPV18 genome (E6153PKA) and compared the effect of this mutation on the HPVl8 life cycle in
primary keratinocytes with the wild-type genome and with a secondmutant genome that lacks the E6 PBM (E6PDZ). Loss of
PKA recognition of E6 was associated with increased growth of the genome-containing cells relative to cells carrying the wild-
type genome, and upon stratification, a more hyperplastic phenotype, with an increase in the number of S-phase competent cells
in the upper suprabasal layers, while the opposite was seen with the E6PDZ genome. Moreover, the growth of wild-type ge-
nome-containing cells was sensitive to changes in PKA activity, and these changes were associated with increased phosphoryla-
tion of the E6 PBM. In marked contrast to E6PDZ genomes, the E6153PKAmutation exhibited no deleterious effects on viral
genome amplification or expression of late proteins. Our data suggest that the E6 PBM function is differentially regulated by
phosphorylation in the HPV18 life cycle. We speculate that perturbation of protein kinase signaling pathways could lead to
changes in E6 PBM function, which in turn could have a bearing on tumor promotion and progression.
While in excess of 150 human papillomavirus (HPV) typeshave been identified, only a small subset has been defined as
carcinogenic; these high-risk viruses cause cancers in the orophar-
ynx, at sites on the skin, and at multiple sites in the anogenital
tract, predominantly the uterine cervix (1–3). In squamous cell
carcinoma of the cervix and oropharyngeal tumors, HPV16 is the
most frequent type, whereas HPV18 is more strongly associated
with cervical adenocarcinoma (4).
The infectious cycle of this small, double-stranded DNA virus
is intimately linked to the terminal differentiation program of the
host cell—the keratinocyte (reviewed in reference 5). The virus
infectsmitotically active keratinocytes within the basal cell layer of
squamous epithelium, gaining access when these cells become ex-
posed through microabrasions in the tissue. Here, the viral ge-
nome replicates as an episome, to levels of50 to 200 copies per
cell, and becomes segregated equally between daughter cells via
synchronous replication with host DNA. Once infected cells mi-
grate up from the basal cell layer, the normal occurrence of with-
drawal of these cells from the cell cycle is prevented by the actions
of the HPV early proteins E6 and E7. By working in cooperation,
E6 and E7 establish a cellularmilieu that supports amplification of
the viral episome to thousands of copies per cell. Finally, expres-
sion of the viral capsid proteins andpackaging of progeny virus are
restricted to the more superficial differentiated cells.
The precise role of E6 in the virus life cycle is not fully under-
stood, but the analysis of E6 mutants in the context of the com-
plete viral genome has shown that E6 functionmakes a significant
contribution to the productive life cycle (6–10). The ability of E6
to stimulate the degradation of p53, the tumor suppressor protein
that is upregulated in response to E7 function in HPV-infected
cells, is important for episomal maintenance in undifferentiated
keratinocytes (8) and potentially for viral DNA amplification in
suprabasal cells (10).However, other functions of E6 distinct from
p53 degradation are also involved in supporting the virus life cycle
(8, 10). One such E6 function is the ubiquitin-mediated proteol-
ysis of a select group of PSD95/DLG/ZO-1 (PDZ) domain-con-
taining proteins (referred to as PDZ proteins). The targeting of
PDZ proteins by E6 is mediated by a C-terminal four-amino-acid
class 1 PDZ binding motif (PBM) (X-S/T-X-V/L). Deletion of the
E6 PBM in the context of the HPV16 and -31 genomes has been
shown to interferewith stablemaintenance of the viral genomes in
keratinocytes, indicating that an intact E6 PBM is required for the
normal E6 function in the infectious cycle (6, 7). To date, some 14
cellular PDZ domain-containing proteins have been shown to in-
teract with E6. These include the human orthologues of the Dro-
sophila melanogaster tumor suppressor proteins Discs Large
(DLG1) and Scribble (hSCRIB) and the MAGUK with Inverted
Domain (MAGI) proteins MAGI-1, -2, and -3 (11–15). These
cellular proteins are primarily involved in the assembly of inter-
cellular adhesion junctions, the regulation of cell polarity, prolif-
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eration, and invasion, and apoptotic processes (reviewed in refer-
ence 16).
Intriguingly, a canonical cyclic AMP (cAMP)-dependent pro-
tein kinase A (PKA) recognition motif (R-R/K-X-T/S) partially
overlaps with the E6 PBMof several high-risk HPV types, with the
critical amino acid at3 of the PBM being the phosphoacceptor
(17). From the analysis of crystal structures of theHPV18 E6 PBM
bound to PDZ domains, phosphorylation of the threonine at3
is predicted to disrupt binding to the PDZ domain through steric
hindrance (18). Indeed, PKA phosphorylation of HPV18 E6
within the PBM has been shown to negatively regulate the inter-
action withDLG1 andMAGI-1, causing inhibition of DLG1 turn-
over by the proteasome, an effect that is dependent on the integrity
of the PKA recognitionmotif within the C terminus of E6 (17, 19).
Intriguingly, it has recently been shown that while phosphoryla-
tion of this domain blocks the interaction with PDZ domain-
containing targets, it enables binding to a non-PDZ domain-con-
taining protein, 14-3-3, in a PKA-dependent manner (19).
Thus, the function of the E6 PBM may be differentially regu-
lated by phosphorylation during the infectious cycle of the virus,
not only to control interactions between E6 and PDZ domain-
containing targets but also to control interactions with other host
cell targets that only recognize the phosphorylated form of the E6
PBM. However, the biological relevance of regulation of this E6
domain in the context of the complete virus life cycle is not
known. Therefore, to address this, we have constructed a muta-
tion within the E6 gene of the HPV18 genome that disrupts the
PKA recognition motif. The mutant genome was transfected into
primary human foreskin keratinocytes (HFK) isolated frommul-
tiple donors and cell lines established. The effect of this E6 muta-
tion on viral episome replication, maintenance, and amplification
was examined and compared to HFK lines containing the wild-
type (WT) HPV18 genome and to a mutant HPV18 genome cod-
ing for an E6 protein lacking the PBM. Our findings support the
hypothesis that phosphorylation of the E6 PBM is an important
mechanism for controlling E6 PBM function during the replica-
tion cycle of the virus.
MATERIALS AND METHODS
Construction of mutant HPV18 genomes and generation of stable cell
lines. A pGEMII plasmid containing the complete HPV18 genome in-
serted at the EcoRI restriction site at nucleotide 2440 (pGEMII18-WT; a
gift from Frank Stubenrauch, University of Tübingen) was used as a tem-
plate for site-directed mutagenesis (QuikChange; Stratagene). Two mu-
tant genomes were generated: pGEMII18-E6PDZ contains three nucle-
otide substitutions (G567¡T, A570¡T, and C571¡G) within the E6 DNA
sequence and inserts translation termination codons at amino acid posi-
tions 155 and 156. The primer set used was 5=-CGACTCCAACGACGCA
GATAATGACAAGTATAATATTAAGTATG-3= (forward primer) and
5=-CATACTTAATATTATACTTGTCATTATCTGCGTCGTTGGAG
TCG-3= (reverse primer). pGEMII18-E6153PKA contains one nucleotide
substitution (G562¡T) within the E6 sequence and replaces amino acid
arginine 153 with leucine. The primer set used was 5=-CTCCAACGACT
CAGAGAAACACAAGTATAA-3= (forward primer) and 5=-TTATACTT
GTGTTTCTCTGAGTCGTTGGAG-3= (reverse primer). Bidirectional
DNA sequencing of the completeHPV18 genomes confirmed insertion of
the mutations and the absence of mutations outside these nucleotide po-
sitions.
Newborn foreskin circumcision tissue samples were collected from
patients attending a general practitioner’s practice with informed written
parental consent (ethical approval no. 06/Q1702/45). Primary HFK were
isolated from the foreskin tissue and maintained in SFM keratinocyte
growth media (Invitrogen, Paisley, Scotland, United Kingdom) as previ-
ously described (20). Low-passage-number J2-3T3fibroblastswere grown
in Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented with
10% newborn calf serum and 4 mM glutamine.
The generation of HPV18 genome-containing cell lines has been de-
scribed previously (21). Briefly, pGEMII18-WT, pGEMII18-E6153PKA,
and pGEMII18-E6PDZ were digested with EcoRI to release the viral
genomes and recircularized in the presence of T4 DNA ligase, and each
was cotransfected with a plasmid carrying the neomycin resistance gene
into second- or third-passage HFK using FuGENE 6 transfection reagent
(Roche, Welwyn Garden City, United Kingdom). One day after transfec-
tion, cells were seeded onto feeder layers of -irradiated J2-3T3 cells and
grown for 8 days in the presence of G418 antibiotic (PAA Laboratories,
Yeovil, United Kingdom) in Emedium containing epidermal growth fac-
tor (BD Biosciences, Oxford, United Kingdom) and fetal calf serum (Hy-
Clone, ThermoFisher Scientific, Cramlington,UnitedKingdom). Emerg-
ing cell colonies were pooled and expanded on -irradiated J2-3T3 cells.
The pGEMII18-WT, pGEMII18-E6153PKA, and pGEMII18-E6PDZ
genomes were transfected into HFK isolated from a minimum of three
different donors.Once cell lineswere established, totalDNAwas extracted
and the presence of the appropriate mutation was confirmed by PCR and
DNA sequencing.
Southern analysis. HPV18-containing keratinocytes were grown as
monolayer cell cultures on-irradiated J2-3T3 cells and harvested once 70
to 80% confluencewas reached. Total DNAwas extracted from the cells as
described previously and analyzed by Southern blotting using an [-
32P]dCTP-labeled HPV18 genomic probe (21).
Organotypic raft culture, chromogenic in situ hybridization (C-
ISH), and immunocytochemistry. Organotypic raft cultures were pre-
pared as previously described (22). Each cell line was grown in an orga-
notypic raft culture at least three times and harvested after 13 days of
growth. To detect cells undergoing cellular DNA synthesis, the synthetic
thymidine analogue bromodeoxyuridine (BrdU) (Sigma-Aldrich, Poole,
United Kingdom) was added to themedium to a final concentration of 20
M for 14 h prior to harvest. Organotypic rafts were fixed in formalde-
hyde and paraffin embedded, and 4-msectionswere taken (PropathUK,
Ltd., Hereford, United Kingdom). Sections were treated with hematoxy-
lin and eosin stain to observe morphology.
For immunohistochemistry, sections were first subjected to low-tem-
perature antigen retrieval, as described elsewhere (23). For detection of
incorporated BrdU, sections were stained with a fluorescein isothiocya-
nate (FITC)-conjugated antibody specific to BrdU (BD Biosciences, Ox-
ford, United Kingdom). Cyclin B1 was detected using the antibodyH-433
(Santa Cruz Biotechnology, Inc.), HPV18 E4 was detected with a rabbit
polyclonal antibody that was raised against a glutathione S-transferase
HPV18 E1^E4 fusion protein (21), and L1 was localized in organotypic
raft sections by using a mouse monoclonal antibody (clone 5A3; Nova-
Castra Laboratories, Newcastle upon Tyne, United Kingdom). Immune
complexes were detected using antispecies antibodies conjugated to Alexa
Fluor 488 or Alexa Fluor 594 (Invitrogen). Nuclei were visualized using
the DNA stain 4=,6-diamidino-2-phenylindole (DAPI).
To detect nuclei positive for viral DNA amplification, sections were
probed with biotin-conjugated HPV DNA probe specific for high-risk
HPV types, using Leica Bond-Max technology, as described by the man-
ufacturer (Leica Microsystems, Milton Keynes, United Kingdom).
Western blotting.Cells grown inmonolayer cell culture were lysed in
a small volume of 50 mM HEPES (pH 7.0), 250 mM NaCl, 0.1% NP-40
supplemented with Complete protease inhibitor cocktail (Roche), soni-
cated briefly on ice prior to clearing the lysate by centrifugation at 16,100 g
at 4°C for 15 min. For preparation of cell lysates from organotypic raft
cultures, the raft was scraped carefully from the fibroblast-embedded col-
lagen base and homogenized in 1 ml of ice-cold lysis buffer (50 mM
Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA, 1% [vol/vol] NP-40
supplemented with Complete protease inhibitor cocktail [Roche]) in a
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glass Dounce homogenizer. Following incubation on ice for 30 min, the
lysate was cleared by centrifugation (16,100 g) for 15 min at 4°C.
Equal amounts of protein were separated by SDS-polyacrylamide
(10%) gel electrophoresis (Tris-glycine), and resolved proteins were
transferred to nitrocellulose membrane. The HPV18 E6 protein was de-
tected using the monoclonal antibody AVC399, kindly donated by Arbor
Vita Corporation (Fremont, CA), and used as previously described (24),
ormonoclonal antibodyG-7 (SantaCruz Biotechnology, Inc.).HPV18E7
was detected using a mouse monoclonal antibody (8E2; Abcam, Cam-
bridge, UnitedKingdom). The rabbit anti-phospho-E6 antibodywas gen-
erated and used as described previously (19). Protein loading was assessed
by detection of GAPDH (glyceraldehyde-3-phosphate dehydrogenase)
using amousemonoclonal antibody purchased from Santa Cruz Biotech-
nology or by detection of 	-actin (Sigma-Aldrich). The signals were de-
veloped using enhanced chemiluminescence (GE Healthcare UK, Ltd.)
and detected by exposure to X-ray film or using the Fusion FX7 image
acquisition system (Vilber Lourmat, France).
In vivo degradation assays. Two micrograms of plasmids expressing
hemagglutinin (HA)-DLG1, Flag-MAGI-1, HA-SCRIB, or p53 was
cotransfected with 4 g of plasmids expressing the various HPV18 E6
proteins or the empty vector into HEK293 or Saos-2 (for p53 only) cells
using Lipofectamine 2000. Cells were harvested after 24 and 48 h and lysed
on ice in urea-containing buffer (9Murea, 25mMTris-HCl [pH7.4], 150
mM NaCl, supplemented with Complete protease inhibitor cocktail
[Roche]). After brief sonication, the protein lysates were cleared by cen-
trifugation (16,100 g) for 15 min at 4°C. Equal amounts of the cleared
lysate were resolved by SDS-PAGE and after transfer to nitrocellulose
immunoblotted with anti-HA (Covance), anti-Flag (Sigma-Aldrich), or
anti-p53 (DO-1) (a kind gift from Roger Grand, University of Birming-
ham) antibodies. The transfection efficiencies of the different plasmids
were assessed by cotransfection of a green fluorescent protein (GFP)-
expressing plasmid.
Cell growth assays. Cells were seeded at a density of 4  104 onto a
layer of -irradiated J2-3T3 cells in six-well plates. Growth of the cells was
monitored for up to 6 days by harvesting and counting the viable cells
following removal of fibroblast feeder cells. Cell-doubling times for the
various cell lines were calculated (http://www.doubling-time.com
/compute.php). To monitor the effects of chemical activators of the
cAMP-dependent PKA pathway on cell growth, forskolin (FK) and
3-isobutyl-1-methylxanthine (IBMX; Sigma-Aldrich) were each solubi-
lized in dimethyl sulfoxide (DMSO) and used in combination at concen-
trations of 50Mand 500M, respectively; dibutyryl-cAMP (Bt2-cAMP)
(Biolog, Hayward, CA) was prepared in Hanks’ balanced salt solution at 1
mM. The modifiers of PKA signaling were added to cell cultures 2 days
after seeding. Cells were harvested following removal of feeder fibroblasts,
and viable cells were counted at 12 and 48 h postaddition of the drug.
Equivalent amounts of DMSO were added as a vehicle control for FK/
IBMX-treated cell cultures. Ten separate cell counts were taken for each
time point, and data were collected from three independent experiments.
Cells treated with FK and IBMXwere also harvested after 2 h of treatment
and lysed in E1A buffer (250mMNaCl, 0.1%NP-40, 50 mMHEPES [pH
7.0]) supplemented with the Complete protease inhibitor cocktail
(Roche) and phosphatase inhibitor cocktail III (Sigma-Aldrich). The pre-
pared lysates were analyzed by Western blotting for expression of phos-
phorylated E6 protein.
RESULTS
The stable maintenance of viral episomes in primary keratino-
cytes is affectedbydeletionof theE6PBM,butnotbydisruption
of the PKA recognition motif. To gain insight into the biological
significance of the PKA recognition motif to E6 function in the
HPV18 life cycle, two separatemutations were constructed within
the E6 gene of the HPV18 genome (Fig. 1A). In the E6153PKA
mutant genome, the essential arginine residue (R153) of the PKA
consensus motif was changed to a leucine residue. In a previous
study, it was shown that a leucine substitution of this arginine in
HPV18 E6 was sufficient to abrogate PKA phosphorylation of E6
in cells (17). Since PKA-mediated phosphorylation of the threo-
nine residuewithin the PBMcould no longer occur, themutant E6
protein degraded the PDZ target DLG1 in a constitutive, PKA-
independent manner (17). In the second mutant genome
(E6PDZ), the four residues that constitute the PBMwere deleted
from the E6 protein by changing the glutamic acid and threonine
codons at positions 155 and 156, respectively, to translation ter-
mination codons (Fig. 1A). The E6 protein expressed from this
mutant genome is unable to target cellular PDZ substrates (11).
To confirm that the mutations behave as predicted toward
PDZ protein substrates, the individual E6 mutant proteins were
examined for their ability to target epitope-tagged PDZ proteins,
DLG1, MAGI-1, and hSCRIB in in vivo degradation assays (Fig.
1B). In HEK293 cells, the E6153PKA mutant protein behaved as
the wild-type E6 protein and targetedDLG1 andMAGI-1 for deg-
radation, albeit showing, relative to the wild-type protein, a mar-
ginally greater efficiency in degrading DLG1 and a slightly lower
efficiency in targeting MAGI-1 for degradation. The wild-type
protein has only a weak effect upon hSCRIB since it is not a pref-
erential PDZ target of the HPV18 protein (25), and likewise, there
is little degradation of hSCRIB in the presence of E6153PKA. As
expected, deletion of the E6 PBM abrogated degradation of the
PDZproteins, while neithermutation inhibited the ability of E6 to
degrade p53 in Saos-2 cells (Fig. 1B). Together, these data indicate
that themutations in the PKA-PDZmodule do not adversely alter
substrate selectivity. Since there was only a slight enhancement in
degradation of DLG1 following expression of the constitutively
activemutant E6153PKA, themajority of the wild-type E6 protein
is likely to be in an unphosphorylated state with regard to the PBM
and thus active toward degradation of its PDZdomain-containing
targets (19). However, we cannot exclude the possibility that mu-
tation of arginine 153, a residue not essential for binding to PDZ
domain-containing substrates, might have a subtle effect on deg-
radation of some targets, such as MAGI-1, that is irrespective of
the phosphorylation status of the protein (26).
HFK were transfected with the wild type HPV18 genome, or
each of the mutant genomes, E6PDZ and E6153PKA, and stable
lines were established. Southern blotting of total genomic DNA
isolated from undifferentiated monolayer cell cultures showed
that the wild-type and mutant viral genomes were established as
extrachromosomal episomes (Fig. 2A). Generally, the E6PDZ
genomes were established as replicating episomes at a lower copy
number than the wild-type or E6153PKA genomes, and further
significant reduction in the level of the E6PDZ episomes oc-
curred upon extended passage of the cells (Fig. 2A and B). The
marked decrease in the number of E6PDZ episomes was accom-
panied by viral DNA integration, as assessed by disruption of the
E2 gene (27) (data not shown). The sharp reduction in the main-
tenance of E6PDZ genomes was observed in four out of five
different donor backgrounds; in three of these, the reduction oc-
curred by passage 11 (equivalent to 44 to 46 cell population
doublings), while in another, they occurred after 76 cell popu-
lation doublings (passage 18). However, in a fifth donor, the level
of E6PDZ genomeswasmaintained at a copy number equivalent
to that of the wild-type episomes even after 108 to 110 population
doublings (passage 27). Reduction in wild-type episomes was also
observed in one of the donor backgrounds, but decreased viral
genomemaintenance occurred at a later passage (passage 18;72
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population doublings) than in the E6PDZ genome-containing
cells (passage 11;46 population doublings [data not shown]).
These data indicate that HPV18 E6 PBM function is necessary
for the efficient establishment of viral episomes and for mainte-
nance of genome replication in primary keratinocytes, findings
that concur with similar mutational studies of the E6 PBM of
HPV16 and HPV31 in immortalized and primary keratinocytes,
respectively (6, 7), although our data indicate that persistence of
the mutant genomes is influenced by the donor background. In
addition, the stable maintenance of the E6153PKA episomes,
even after extended passaging of the cells, suggests that the loss
of PKA regulation of the E6 C-terminal PBM does not adversely
affect long-term maintenance of replication of the HPV18 ge-
nome (Fig. 2A).
In order to ensure that the mutations do not adversely affect
the levels of E6 and/or E7 expression, the steady-state protein
expression levels of the two viral oncoproteins were assessed in
lysates prepared from cells grown in monolayer culture and fol-
lowing stratification in organotypic raft culture for 13 days (Fig.
2C). Western blotting of equivalent amounts of protein showed
little variation in the expression levels of both oncoproteins be-
tween the various cell lines in undifferentiated cells or in the strat-
ified cultures. These results indicate that the nucleotide changes
within the E6 gene do not adversely affect E7 protein production
and the alteration in PBM activity is not associated with any
change in the steady-state expression of the E6 protein in primary
keratinocytes.
The integrity of the E6 PBM is critical for differentiation-
dependent HPV18 vegetative functions in primary keratino-
cytes. To investigate the effect of changes to E6 PBM function on
epithelial stratification and the productive virus life cycle, organo-
typic raft cultures of the various cell lines were grown, and paraf-
fin-embedded formalin-fixed sections were stained with hema-
toxylin and eosin (Fig. 3A). In comparison to structures produced
from normal primary keratinocytes, the presence of the wild-type
HPV18 genomes was associated with a thickening of the parabasal
and spinous cell layers and occurrence of areas where nuclei had
been retained throughout all layers of the stratified structures, as
previously shown (21, 22). Organotypic rafts produced from cells
carrying the E6153PKA genomes had a similar morphology to the
wild-type genome rafts, with the exception that they generally
showed greater thickness of the nucleus-containing cell layers
(Fig. 3A). In contrast to the morphology of the wild-type or
E6153PKA rafts, the overall thickness of rafts produced from
E6PDZ cells was consistently reduced, and their appearance
more closely resembled the morphology of the structures pro-
duced from the untransfected donor cells. A similar phenotype
was also reported for HPV31 genomes that lacked the E6 PBM (6)
and for HPV18 genomes that were unable to express a full-length
E6 protein (10). Staining of the rafts with markers of epidermal
differentiation showed that the pattern of expression of both early
(differentiation-specific keratins) and late (involucrin and filag-
grin) markers in the presence of the mutant genomes was similar to
that of rafts containing the wild-type genomes (data not shown).
FIG 1 Details of E6 C-terminal mutations in HPV18 genomes and analysis of the activity of these mutations in an in vivo degradation assay. (A) Two mutant
HPV18 genomes were constructed. E6PDZ contains base substitutions at nucleotides 567, 570, and 571, thereby altering the codons for glutamic acid 155 and
threonine 156 to translation termination codons. This mutant genome supports expression of an E6 protein in which the PBM, ETQV, is deleted. E6153PKA
contains a single base substitution at nucleotide 562 that alters the codon for arginine 153 to leucine; the mutant protein expressed from this genome is not a
substrate for PKA and targets cellular PDZ proteins in a constitutive, PKA-independent manner (17). The position of the initiator methionine codon for the E7
protein, which is separated from the translation termination codon of E6 by 8 nucleotides, is indicated. (B) In vivo E6-mediated degradation assays of
epitope-tagged PDZ domain-containing targets (DLG1,MAGI-1, and SCRIB) and p53. Urea-soluble cell extracts were harvested at 24 and 48 h posttransfection,
and the level of E6 targets was assessed byWestern blotting. Each antibody data set (all four transfections) was taken from the same exposure. Shown below each
degradation experiment are the amounts of PDZ proteins or p53 remaining relative to the transfections with empty vector (following normalization to the
loading control [GAPDHor	-actin]). The efficiency of transfections of each set of expression plasmidswasmonitored by inclusion of aGFP-expressing plasmid,
and the efficiencies were shown to be equivalent (WT, 32%; E6153PKA, 33%; E6PDZ, 32%) between the cotransfections.
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To determine if the changes in E6 PBM activity affected viral
genome amplification, chromogenic in situ hybridization (C-
ISH) using an HPV-specific probe was performed on organotypic
raft sections. As shown in Fig. 3B, intensely stained nuclei indicat-
ing cells undergoing viral DNA amplification are prominent in
cells of the upper suprabasal cell layers of rafts of cells carrying the
wild-type genomes, but not in rafts of the untransfected donor
keratinocytes. A similar pattern of viral DNA amplification was
also evident in E6153PKA rafts, but not in the E6PDZ rafts,
where HPV DNA-positive nuclei were rarely observed. Quantifi-
cation of the data in this donor keratinocyte background showed a
significant reduction (P
 0.005) in the number of cells undergo-
ing viral genome amplification in the absence of a functional E6
PBM, an observation that was consistent across the different do-
nors (Fig. 3B). For the generation of the E6PDZ rafts, cells were
used prior to loss of detection of episomes. Since the steady-state
levels of E6 and E7 protein expression between the wild-type and
mutant genomes were equivalent (Fig. 2C), this confirmed the
presence of the genomes in these cells.
Expression of the viral capsid proteins occurs in the more dif-
ferentiated cells, so to determine if changes in E6 PBM activity
affect capsid production, rafts were stained with an antibody that
recognizes the major capsid protein L1 (Fig. 3C). Sections were
costained for the E4 protein, since the function of this protein has
been shown to be necessary for efficient genome amplification and
late viral gene expression (21, 28, 29). In rafts produced from cells
containing viral genomes that retain a functional E6 PBM (WT
and E6153PKA), abundant E4 staining occurred in the cytoplasm
of cells of the mid and upper suprabasal cell layers, and a propor-
tion of the nuclei in these cells were dual stained for the L1 protein
(Fig. 3C). However, in E6PDZ raft sections, only an occasional
suprabasal cell was positive for E4 and L1 protein expression (Fig.
3C). Taken together, these data indicate that disruption of the
PKA recognition motif at the C terminus of E6 does not adversely
affect the ability of the mutant genomes to support vegetative
functions following stratification in organotypic raft culture and
therefore suggest that a constitutively active E6 PBM is not detri-
mental to the vegetative cycle. However, loss of E6 PBM function
severely affects the vegetative cycle, with a significant reduction in
the number of cells that support viral DNA amplification and the
expression of late viral proteins, suggesting that targeting of cellu-
lar PDZ proteins is required for efficient viral replication in su-
prabasal keratinocytes.
Changes in E6 PBM function affect S-phase activity in the
basal and suprabasal compartments of organotypic raft cul-
tures. Amplification of HPV genomes in postmitotic differenti-
FIG 2 Stable maintenance of HPV18 episomes is dependent on E6 PBM function but independent of PKA recognition. (A) Southern analysis of equal amounts
of totalDNAextracted fromHFK transfectedwithwild-type (HPV18-WT) ormutant (HPV18-E6PDZandHPV18-E6153PKA) genomes upon serial passaging
of the cells. To assess for the presence of episomal forms (supercoils and open circles) of the viral genome, the DNA was restricted with the endonuclease BglII,
which does not digest the HPV18 genome. To control for the presence of bacterially derived input DNA, the digests included the endonuclease DpnI. Linearized
HPV18 genomes are shown as a copy number control (lane C [5 copies per cell]). (B) The E6PDZ genomes establish at a lower copy number in HFK than the
WT genomes, as shown by Southern analysis of total DNA taken from three different donors (passages P5 and P6) and digested with EcoRI, which linearizes
HPV18 episomes, andDpnI (lane C, 5 copies per cell). (C)Detection of E6 and E7 proteins in equal amounts of NP-40 detergent-soluble protein lysates prepared
from cells grown in monolayer cultures or from organotypic raft cultures. Levels of GAPDH were used as a loading control.
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ated cells is dependent on reactivation of the host’s cellular DNA
replicationmachinery. This is largelymediated by the ability of E7
to stimulate S-phase reentry of these cells, although this activity
can also be augmented by E6 (30, 31). To confirm that a su-
prabasal S-phasemilieu is promoted in the presence of themutant
E6 proteins, organotypic raft cultures were incubated with the
thymidine analogue bromodeoxyuridine (BrdU) 14 h prior to
harvest, and sections were stained with an anti-BrdUmonoclonal
antibody to identify cells undergoing cellular DNA synthesis (Fig.
4A). Replication of the host chromosome is restricted to cells of
the basal cell layer in raft cultures of the untransfected HFK, while
in wild-type and mutant genome-containing raft cultures, BrdU-
positive nuclei were detected in basal and suprabasal epithelial
compartments, indicating that the mutant genomes support S-
phase reentry of the differentiating cells. Interestingly, quantifica-
tion of the number of BrdU-positive nuclei within the different
epithelial layers of the raft revealed significant differences between
the mutants and the wild-type genome-containing cells (Fig. 4A).
While the numbers of BrdU-positive cells confined to the basal
layers did not vary significantly between the untransfected HFK
and wild-type genome-containing rafts (35% versus 36%),
there was a decrease in the S-phase population in E6153PKA rafts
(23%), and in E6PDZ rafts, this population increased
(48%). Within the parabasal and lower spinous layers (referred
to as lower suprabasal) of the wild-type and bothmutant rafts, the
numbers of BrdU-positive cells were comparable (WT, 21%;
E6153PKA, 19%; E6PDZ, 27%). However, significant dif-
ferences in the S-phase active population were observed in the
upper suprabasal compartment (consisting of the upper spinous
and granular layers); in comparison to wild-type genomes
(18%), BrdU-positive nuclei were greatly increased in
E6153PKA rafts (36%) but markedly decreased in the presence
of the E6PDZ genomes (7%). The data shown were derived
from four different donor backgrounds (Fig. 4A).
These data indicate that the loss of PDZ targeting by E6 does
not prevent cells from entering S phase as they leave the basal layer
and begin to migrate upwards, but the PBM is detrimental to the
maintenance of S-phase competent cells in the upper suprabasal
layers. This is a likely explanation for the marked decrease in cells
competent for viral genome amplification. High-level synthesis of
the viral genome occurs in suprabasal cells that have moved from
S phase into G2, and these G2-arrested cells are identified by accu-
FIG3 E6PBM function is required for viral genome amplification and expression of E4 and L1 in suprabasal keratinocytes. (A) To show themorphological detail
of the stratified structures, sections of organotypic rafts were stained with hematoxylin and eosin. It is important to note that for organotypic raft culture of
E6PDZ cells, it was ensured that cell passages prior to loss of viral episomes were used. (B)Nuclei positive forHPV18DNA amplification (brown staining) were
identified by chromogenic ISH. Viral DNA-positive nuclei were rare in sections of E6PDZ rafts, with an example shown enlarged in the inset. Scale bar, 25m.
The graph shows the percentage of suprabasal cells containing HPV 18DNA-positive nuclei for HFK,WT, E6PDZ, and E6153PKA genome-containing cells in
different donor backgrounds (brackets 1 and 2). The data, shown as means with standard deviations (**, P
 0.01, Student’s t test), were derived from five fields
of view of each section of raft, with between 450 and 1,350 cells counted for each raft section. (C) Sections of rafts stained for E4 (green) and L1 (red) and nuclei
visualized usingDAPI staining (blue). Suprabasal cells of raft cultures ofWTandE6153PKAgenomes showed areas of E4 and L1 staining, but E4- and L1-positive
cells were rarely observed in rafts of E6PDZgenome-containing cells. No E4 or L1 staining occurred in raft cultures of donor keratinocytes (HFK).White dotted
lines indicate the basal cell layer.
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mulation of cytoplasmic cyclin B1. We observe a significant de-
crease of 63% (combined data taken from three donor back-
grounds; P  0.0001) in this population of G2-arrested cells
following staining of the E6PDZ rafts with a cyclin B1 antibody,
relative to the wild-type genome-containing rafts, further illus-
trating the failure of E6PDZ cells tomaintain cell cycle activity in
the upper cell layers (Fig. 4B).
Recent studies suggest that elevated levels of p53, induced in
response to the activity of E7 in suprabasal keratinocytes, suppress
viral DNA amplification. High-risk E6 proteins negate this host
response by destabilizing p53. Deletion of the E6 PBM does not
affect the ability of E6 to destabilize p53 in vivo (32) (Fig. 1B), and
furthermore, we observed no increase of p53 protein expression in
E6PDZ differentiated cells compared to cells carrying the wild-
type genomes (Fig. 4C).
In contrast to the E6PDZ mutation, disruption of the PKA
recognition motif that is critical for the phosphorylation of the
PBMdomain is associatedwith amarked increase in S-phase com-
petent cells in the upper suprabasal cell layers, although this does
not correlate with an increase in the number of cells amplifying
their genomes relative to the wild-type genome-containing rafts
(Fig. 3B). Indeed, there is no increase in the number ofG2-arrested
cells in the E6153PKA rafts upon comparison with those formed
from cells carrying the wild-type HPV18 genomes (Fig. 4B).
Disruption of the PKA recognition motif of E6 leads to an
increase in the rate of growth of HPV18 genome-containing
cells. The above results indicate that the E6153PKA genome-con-
taining cells exhibit more of a hyperproliferative phenotype than
cells containing the wild-type genome following organotypic raft
culture (Fig. 3 and 4). To determine whether the growth of these
cells was also affected in monolayer cell culture, cells were grown
on-irradiated J2-3T3 fibroblasts and harvested at 2, 4, and 6 days
after seeding. Viable cells were counted after removal of fibro-
blasts, and the combined analysis of the growth rates of cells from
all three donor backgrounds is shown in Fig. 5A. In all of the
different donor backgrounds, as expected, the wild-type HPV18
genome-containing cells grew at a higher rate than the untrans-
fected donor primary keratinocytes (HFK). Deletion of the E6
PBM was associated with a marked reduction in the rate of cell
growth with a significant increase in the doubling times of
E6PDZ cells compared to thewild-type genome-containing cells
(Fig. 5A), a finding that concurs with a similar E6 deletion in the
HPV31 genome (6). Moreover, as was also noted in the study of
the HPV31 genomes, the growth of cells containing viral genomes
lacking an E6 PBM is slower than the parent keratinocytes (Fig.
5A). In contrast, those cells carrying the E6153PKA genomes grew
faster than the wild-type genome-containing cells, with a signifi-
cant decrease in their doubling times. These data indicate that a
function of the HPV18 E6 PBM is to facilitate efficient growth of
primary keratinocytes and suggest that the conditional regulation
of the E6 PBM by a cellular kinase has a role to play in controlling
the growth of the viral genome-containing keratinocytes.
Activation of PKA signaling in HPV18 genome-containing
cells attenuates cell growth. In light of our findings, the effect of
increasing PKA activity on the growth of cells containing the wild-
type HPV18 genome or the E6153PKA genome was investigated.
PKA activity was stimulated by increasing intracellular cAMP lev-
els, either by the addition of forskolin (FK) and 3-isobutyl-1-
methylxanthine (IBMX) in combination or the cell-permeable
PKA activator, dibutyryl-cAMP (Bt2-cAMP) to themonolayer cell
cultures. Cells were seeded onto -irradiated J2-3T3 feeder cells,
the chemical activators were added after 48 h, and viable cells were
counted subsequently at 12 and 48 h.Where appropriate, identical
amounts of vehicle were added to parallel cell cultures. In the
presence of FK/IBMX, the growth of wild-type genome-contain-
ing cells was significantly repressed at both time points in com-
parison to the untreated cells, a consistent effect between different
FIG 4 Changes in basal and suprabasal cellular DNA synthesis correlate with
the activity of the E6 PBM. (A) Organotypic raft cultures were incubated with
BrdU to identify nuclei positive for cellular DNA synthesis. Immunofluores-
cence staining was performed with an anti-BrdU antibody (green), and nuclei
were visualized using DAPI staining (blue). The arrowheads identify the basal
cell layer, and the dotted line differentiates the lower and suprbasal cell layers.
The bar graph shows the percentage of basal, lower suprabasal (parabasal and
lower spinous), and upper suprabasal (upper spinous and granular layers)
nuclei positive for BrdU incorporation, which was calculated from multiple
(between 4 and 6) fields of view of raft sections using a 20 objective. The data,
shown as the means  standard errors, are from four different donor lines.
Statistical analysis was performed using Student’s t test. (B) Sections of orga-
notypic rafts stained with an anti-cyclin B1 antibody (green) and counter-
stained with DAPI (blue). The percentage of suprabasal cells positive for cyto-
plasmic cyclin B1 expression, calculated from 10 fields of view and from three
different donor lines, is shown as the mean  standard error. The paired
Student’s t test showed that the difference between E6PDZ andWT rafts was
significant (P 0.0001). Arrowheads indicate the basal cell layer. (C)Western
blot analysis of p53 protein expression in NP-40-containing lysates prepared
from organotypic raft cultures showed no marked changes in p53 protein
levels between the different mutants (E6PDZ and E6153PKA) and the cells
containing wild-type (WT) genomes. Levels of GAPDH were used to control
for protein loading. HFK, untransfected primary keratinocytes.
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donors (Fig. 5B). In contrast, there was no significant change in
the growth profile of E6153PKA genome-containing cells follow-
ing addition of the PKA activators. A similar profile of growth
response was also observed following the addition of Bt2-cAMP
(Fig. 5B). These data indicate that only the growth of cells contain-
ing an HPV18 genome with an E6 PBM that is amenable to regu-
lation by PKA is decreased in response to increased PKA activity.
To determine if stimulation of PKA signaling is associated with
phosphorylation of E6 in the genome-containing cells, lysates
were prepared from cells treated with FK and IBMX in combina-
tion or by vehicle alone. Equal amounts of the lysates were ana-
lyzed by Western blotting using an antibody that detects total E6
and an anti-phospho E6 antibody that recognizes the phosphory-
lated HPV18 E6 PBM (19). TheWestern blot (Fig. 5C) shows that
in the absence of PKA stimulation, E6 expressed from the wild-
type genomes appears to be only weakly phosphorylated. How-
ever, increased E6 phosphorylation is observed following incuba-
tion of cells with FK and IBMX (Fig. 5C). While E6 could be
detected in the E6153PKA genome-containing cells, there was no
indication that it was phosphorylated in the absence or presence of
PKA activators. These data suggest that E6 expressed in wild-type
genome-containing cells is susceptible to PKA phosphorylation
within the PBMand that this phosphorylation is dependent on the
integrity of the overlapping PKA recognition site.
DISCUSSION
Disruption of the integrity of the E6 PKA-PBM module in the
complete HPV18 genome has profound effects upon keratinocyte
growth and upon the viral life cycle. In a submerged monolayer
culture, this effect is linked to PKA signaling since the growth of
cells carrying the wild-type genomes decreases upon PKA activa-
tion and this is associated with increased phosphorylation of the
E6 PBM. Loss of phospho-regulation, which renders E6 constitu-
tively active for PDZ binding, is also associated with a more hy-
perplastic phenotype following stratification of the cells in an or-
ganotypic raft culture. The stratified structures are thicker than
those produced from cells carrying the wild-type genomes, and
there is a significant increase in the percentage of S-phase compe-
FIG 5 Activation of PKA signaling inHPV18 genome-containing cells attenuates cell growth. (A) Cell growth profiles of untransfected keratinocytes (HFK) and
of HPV18 genome-containing cells generated in three donor backgrounds. Growth profiles were performed in duplicate for each donor and performed as three
independent experiments. Bar graph, change in cell doubling time of the mutant genome-containing cell lines (E6PDZ and E6153PKA) and the untransfected
cells (HFK) relative to cells carrying wild-type genomes (WT). Data are shown asmeans standard errors, and statistical analysis was performed using Student’s
t test. (B) Growth assays of HPV18 genome-containing cells (WT or E6153PKA) treated with PKA activators () or vehicle () 48 h postseeding (arrowheads).
Viable cells were counted at 12 and 48 h post-drug treatment, after removal of fibroblast feeder cells. Each data point ( standard deviation) shows data collected
from 10 separate counts for each time point and from triplicate experiments. The data from two separate donor backgrounds are shown for treatment with
dibutyryl cAMP. HPV18-WT (IBMX/FK), 72 h, P
 0.01, 96 h, P
 0.001; HPV18-WT (dibutyryl-cAMP), donor 1, 72 h, P
 0.001, 96 h, P
 0.01; donor 2, 72
h, P
 0.5, 96 h, P
 0.01. (C) Detection of phosphorylated E6 (E6-P) and total E6 (E6) in equal amounts (30g) of cell lysates prepared fromWT or E6153PKA
genome-containing cells treated with FK/IBMX () or vehicle (). HFK cell lysates were included to assess for specificity of the antibodies, and levels of protein
loading were assessed using 	-actin.
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tent cells in the upper suprabasal cell layers (cells of the upper
spinous layers and granular layers). This is in contrast to the mor-
phology of rafts produced by cells containing genomes in which
the E6 PBM has been deleted. These cells formed much thinner
stratified structures, resembling those produced from the un-
transfected parent primary keratinocytes. In addition, there was a
significant decrease in the percentage of S-phase cells in the upper
suprabasal cell layers. These findings are consistent with studies in
mice that showed that the E6 PBMwas required for the hyperpro-
liferative growth of mouse epithelium (32, 33). However, the
numbers of BrdU-positive cells in the lower suprabasal layers,
consisting of cells of the parabasal and lower spinous layers, were
no different between the wild-type and mutant genomes. This is
not surprising since reactivation of S-phase functions in cells as
they migrate up from the basal cell layer is largely mediated by E7
(30). Taken together, our data indicate that the E6 PBM plays a
critical role in the expansion of the S-phase competent cell popu-
lation in the more differentiated cell layers. Failure to maintain
this cell population is a likely explanation for the inability of the
E6PDZ mutant genomes to support viral DNA amplification in
the upper suprabasal layers. Indeed, we observed fewer cells ar-
rested in G2/M in these layers, the point in the cell cycle in which
viral DNA amplification is thought to occur (10). While the me-
chanics of E6 PBM action on the expansion of these postmitotic
cells are not yet clear, it is intriguing that the mutation of known
E6 PDZ domain-containing targets, DLG1 and Scribble in Dro-
sophila, leads to hyperplastic overgrowth and loss of cell polarity of
epithelial cells (34, 35).
The morphology of the organotypic rafts produced from the
E6PDZmutation is very similar to that observed in primary cells
containing HPV18 genomes that are unable to synthesize full-
length E6 (10, 36). Restoration of a wild-type morphology oc-
curred upon ectopic expression of HPV18 E6 in trans but inter-
estingly also with mutant proteins defective in p53 targeting,
indicating that this activity of E6 is independent of p53 inactiva-
tion (36). In fact, although p53 is implicated in regulating viral
DNA amplification, other cellular factors are likely to be involved,
and these may be modulated by the E6 PBM function (36).
One other intriguing difference between the wild-type and
mutant genomeswas the level of S-phase activity in the basal layers
of the rafts. Loss of PDZ domain targeting was associated with
increased frequency of cells undergoing host cell DNA synthesis in
this cellular compartment, while those cells containing genomes
that have lost PKA regulation and have constitutively active PDZ
binding potential were less proliferative. This observationwas sur-
prising in light of the growth behavior of these cells in submerged
monolayer culture, where the opposite effects were obtained.
However, monolayer cultures are nonpolarized cells undergoing
symmetrical cell division, whereas in the rafts, the basal cells
would exhibit apicobasal polarity and undergo asymmetrical as
well as symmetrical division, cell processes that are regulated by
some of the PDZ domain-containing targets of E6 (37, 38).
Whether this phenotype is a reflection of the constitutive targeting
of PDZ domain-containing substrates of E6 or a reflection of the
inability of E6 to interact with potential phospho-dependent tar-
gets (such as 14-3-3 proteins) (19) remains to be determined.
Clearly, loss of PKA regulation of the E6 PBM does not inter-
fere with the establishment or persistence of the HPV18 genomes.
Deletion of the PBM, however, is linked to poor establishment of
replication and a failure to maintain the viral episomes, a biology
that is conserved between similar mutant genomes of other high-
risk HPV types (6, 7). One would therefore predict that in these
cells most of the E6 is likely to be unphosphorylated, since phos-
phorylation might be expected to mimic the E6PDZ phenotype.
Indeed, using phospho-specific antibodies directed against the
HPV18 E6 phospho-PBM, very low levels of phosphorylated E6
are present in the monolayer cultures, while activation of PKA
signaling induces a dramatic increase in the amount of phosphor-
ylated E6. Furthermore, the steady-state levels of the wild-type
and mutant E6 proteins are comparable in our HPV18 genome-
containing cell lines, indicating that a change in E6 protein stabil-
ity is an unlikely explanation for the phenotypes observed in pri-
mary keratinocytes.
How phosphorylation of the E6 PBM regulates the interaction
with PDZ protein targets during the virus life cycle is far from
clear. Structural studies of E6 PBM-PDZ complexes suggest that
phosphorylation of the critical residue in the PBM would simply
inhibit E6’s ability to dock with PDZ domain-containing sub-
strates (17–19). However, disentangling the biological effect of E6
PBM phosphorylation is complicated by the recent finding that
phosphorylated E6 gains the ability to interact with cellular pro-
teins that recognize this phosphorylated motif, such as 14-3-3
proteins (19). Thus, differential targeting of cellular proteins by
E6 in the virus life cycle may be regulated by phosphorylation of
E6 C-terminal sequences (39).
The evolutionary restriction of the E6 PBM to only those HPV
types within the Alphapapillomavirus genus implicated as the eti-
ological agents for the development of mucosal epithelial cancers
suggests that the functions of the E6 PBM contribute to the onco-
genic potential of these viruses, and indeed this is supported by
both cell-based and animal studies (13, 32, 40–42). As reported
here and elsewhere (6, 7), loss of E6 PBM function in the context
of whole viral genomes is associated with viral DNA integration, a
critical event in HPV carcinogenesis. On the other hand, abroga-
tion of kinase recognition of the E6 PBM function is associated
with increased cell growth of viral genome-containing cells and
has also been associated with the enhancement of morphological
transformation of keratinocytes (42). Therefore, it is reasonable to
speculate that perturbation of the protein kinase signaling path-
ways that modulate E6 PBM function could lead to significant
changes in E6 PBM function, which in turn could have a bearing
on tumor promotion and progression.
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